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1. Introduction
Monitoring the electrocardiogram (ECG) 
is one of the greatest interests to both 
healthcare providers and patients alike 
since it manifests the heart’s condition 
with a relatively simple setup. Many car-
diac abnormalities such as myocardial 
ischemia/infarction and several types of 
arrhythmia can be detected by inspecting 
the waveforms collected by ECG.[1,2] ECG 
also provides clinicians a range of indi-
rect measures of the patient’s condition 
including prognostic estimation, postoper-
ative recovery, drug efficacy, mental stress, 
and risk of sudden cardiac death.[3–9] For 
the latter type of investigations, health-
care providers need to assess the heart for 
extended periods and evaluate the trends 
in long-term cardiac activities to make 
appropriate clinical decisions. In these 
scenarios, the standard method for diag-
nosis is a Holter monitor, a portable ECG 
device that can be strapped to the patient 
for a 24 h ambulatory ECG recording. 
Commercially available health monitors rely on rigid electronic housing 
coupled with aggressive adhesives and conductive gels, causing discomfort 
and inducing skin damage. Also, research-level skin-wearable devices, while 
excelling in some aspects, fall short as concept-only presentations due to 
the fundamental challenges of active wireless communication and integra-
tion as a single device platform. Here, an all-in-one, wireless, stretchable 
hybrid electronics with key capabilities for real-time physiological moni-
toring, automatic detection of signal abnormality via deep-learning, and a 
long-range wireless connectivity (up to 15 m) is introduced. The strategic 
integration of thin-film electronic layers with hyperelastic elastomers allows 
the overall device to adhere and deform naturally with the human body while 
maintaining the functionalities of the on-board electronics. The stretchable 
electrodes with optimized structures for intimate skin contact are capable of 
generating clinical-grade electrocardiograms and accurate analysis of heart 
and respiratory rates while the motion sensor assesses physical activities. 
Implementation of convolutional neural networks for real-time physiological 
classifications demonstrates the feasibility of multifaceted analysis with a 
high clinical relevance. Finally, in vivo demonstrations with animals and 
human subjects in various scenarios reveal the versatility of the device as 
both a health monitor and a viable research tool.
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Despite its value in the acquisition of long-term ECG data, 
Holter monitors have limitations as the following: 1) the entire 
set up, which includes the data acquisition unit, bundles of 
cables, gelled adhesives electrodes, tapes and a strap, obstruct 
the natural movements of the patient’s body and create extreme 
discomfort which disrupt daily activities and sleep, 2) gels can 
dry over time and degrade the signal qualities, 3) gels and 
adhesives can cause skin irritation, 4) the user cannot shower, 
adding to the overall discomfort, 5) since the equipment needs 
to be returned to the clinic for data transfer and analysis, it 
requires the patient to plan additional visits, and 6) clinicians 
will be observing cardiac events of the past: it is impossible 
to perform a timely intervention when unexpected cardiac 
events occur. Consequently, there is a high demand for a car-
diac monitoring solution that provides not only the acquisition 
of clinical-grade ECG, but also the form factor non-disruptive 
to everyday tasks as well as the real-time, continuous analysis 
of the patient’s ECG for both improved diagnosis and timely 
intervention. Numerous commercially available wearable 
ECG monitors have been presented; however, these devices 
lack the mechanical compliance for skin and induce physical 
stresses to the application site due to the rigid construction of 
the electronics.[10] Furthermore, the application of the devices 
relies on aggressive acrylic-based adhesives and exposes the 
patients to potential tissues damages during the removal pro-
cess—key disadvantage that restricts the use of technology for 
neonate or young children who have fragile skin conditions.[11] 
While several research studies attempted to address above-
mentioned issues associated with commercial wearable cardiac 
monitors, the presented devices fall short as feasible solutions 
due to the nature of “sensor-only” presentation, incorpora-
tion of a rigid printed circuit board, short-range wireless con-
nectivity, or use of a conductive gel,[12–18] the use of which is 
not desirable due to potential skin irritation and drying over 
long-term recordings. Here we present the first demonstration 
of a wireless, “all-in-one” stretchable hybrid electronic system 
(SHE) that can monitor the user’s real-time cardiac conditions 
through the continuous assessment of the recorded ECG as 
well as the detection and notification of clinically significant 
cardiac events. ECG-derived heart rate (HR) and respiratory 
rate (RR) along with the onboard motion sensor provide valu-
able and critical set of physiological information without com-
promising device’s formfactor. The hyperelastic construction 
allows the device to deform naturally with user’s movement 
while supplying sufficient adhesive forces to adhere the device 
throughout daily activities and strenuous exercises. Since a 
skin-conformal, low-modulus elastomer has shown negligible 
skin irritation,[19,20] three gold ECG electrodes are integrated 
with the elastomer substrate to allow the formation of a gapless 
electrode-to-skin interface and obviate the need for the use of 
conductive gels. The hybrid integration of miniature electronic 
packages with an ultrathin interconnection platform allows the 
on-board implementation of advanced signal processing and a 
long-range Bluetooth connectivity. The low-modulus elastomer 
constitutes the majority of SHE, allowing the device to impart 
overall stretchability despite the presence of non-stretchable 
components, such as the interconnection and chips. Contin-
uous wireless connectivity with increasingly powerful smart-
phones and tablets allow for deployment of deep learning 
solutions, such as convolutional neural networks (CNNs), for 
real-time analysis of patient conditions that are readily acces-
sible. In this study, implementation of two CNNs incorporating 
inception-type convolutional units with residual connections are 
demonstrated for classifying user activity from acceleration and 
angular velocity,[21] and semantic segmentation of ECG ectopic 
beats and arrhythmias for cardiac conditions.[22] To determine 
accuracy, two publicly available ECG datasets, the PTB Diag-
nostic ECG Database and the St. Petersburg Institute of Car-
diological Technics 12-lead (INCART) Arrhythmia Database, 
are used to evaluate the machine-learning model using fivefold 
cross-validation.[23] Finally, feasibility of the device for diverse 
clinical and research scenarios are investigated by conducting 
the treadmill exercises, prolonged application exceeding one 
week, and animal study involving moving rats.
2. Results
2.1. Overview of the System Architecture and Functionalities  
of Ambulatory Health Monitoring
Figure 1A illustrates the main structural and functional compo-
nents that make up the wireless, stretchable hybrid electronics 
(SHE), while Figure 1B describes the layer-by-layer structure 
of the on-board flexible electronics. The assembly process con-
sists of four phases: 1) fabrication of the thin-film circuit and 
nanomembrane electrodes, 2) transfer of the thin-film struc-
tures to elastomeric substrates, 3) circuit assembly by reflow 
soldering of the surface mount components, and 4) final pack-
aging including electrode connection, elastomer encapsulation, 
creation of the oil chamber, and magnet attachment for the bat-
tery connection. We utilized a set of standard microfabrication 
steps to construct the thin, flexible, and stretchable polymer/
metal composite structures and to laminate onto an elastomeric 
substrate. Conventional reflow soldering using a solder paste 
(SMDLTLFP10T5, Chip Quik) and surface mount chip com-
ponents were used for circuit assembly, following previously 
reported methods.[24,25] Details of the fabrication process are 
described in the Supporting Information (Figure S1 and Note S1), 
and the description of the circuit design and the chip compo-
nents can be found in the Supporting Information (Figure S2 
and Table S1). Since the major structural component that 
comprises the SHE is prepared by casting a mixture of elasto-
mers with extremely low moduli, the device is naturally adhe-
sive to the skin and compliant for stretching and bending 
(Figure 1C,D). The integrated circuit components are fully 
concealed and isolated by the elastomer and are powered by an 
external power source, such as the miniature lithium-ion poly-
mer battery (DTP301120, Shenzhen Data Power Technology). 
Supporting Information (Figure S3) details the powering of 
the SHE using the magnetic electrical interfaces, the power 
efficiency of the device, and waterproofing strategy for contin-
uous monitoring even in the presence of water. The set of three 
nanomembrane gold electrodes that contact the skin are pat-
terned photolithographically into a network of repeating units 
of circular islands bridged with meander lines (inset photo 
in Figure 1C), allowing for both stretchability and conformal 
contact to the skin. The electrodes are configured in a bipolar 
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Figure 1. Overview of the SHE and data management. A) Schematic illustration showing the main structural components and their assembly for SHE. 
B) Blow-up rendering image detailing the layer information of the flexible circuit. C) Photo of an SHE showing the soft and adhesive property for direct 
lamination with the skin without the use of adhesives. D) Side view of delamination sequence of the ultrathin device with no negative effects to the skin. 
E) Detail inspection of ECG acquired by the SHE in (C) and identification of PQRST waves, J-point, and ST-segment angle. Inset diagram describes the 
position of SHE (red dot) and polarity of the two measurement electrodes. F) Scatter plot showing the angle and amplitude distribution of ST-segments 
of the ECG data in (E). G) Flow-chart illustration of a real-time, smart, and ambulatory health monitoring, enabled by the SHE.
www.advancedsciencenews.com
1900939 (4 of 14) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedscience.com
setup and are intended to mimic precordial (transverse plane) 
lead V2, which we refer to as Modified Lead V2 (MLV2). From 
experimentation, we determined that the bipolar surface elec-
trodes produce an accurate V2 analog lead. To verify the quality 
of ECG acquired by the SHE, we inspected the collected wave-
form in detail as shown in Figure 1E,F. As the results show, the 
SHE is fully capable of capturing the details of the human ECG 
including all of P wave, T wave, QRS complex, ST-segment, 
and J-point, the dynamics of which are useful markers asso-
ciated with asymptomatic ischemia.[26,27] The acquired ECGs 
were also compatible with clinically relevant analysis, such as 
the R-R variation, low-frequency band (LF)/high-frequency 
band (HF) ratio, pNN50 (time domain measure of heart rate 
variability), and SD1/SD2 (standard deviation ratio from heart 
rate variability), confirming the SHE’s performance in clinically 
relevant ECG acquisition (Figure S4, Supporting Information). 
The flowchart diagram in Figure 1G describes the overview of 
the method with which SHE is utilized for continuous patient 
monitoring. The raw physiological data are transmitted via 
Bluetooth to the connected mobile Android device, where they 
are processed through the CNN-based deep-learning algo-
rithms and classified into subcategories in real time. Further, 
the ECG is simultaneously conditioned using R-peak detection 
and interpolation algorithms to determine the user’s HR (beats 
min−1) and RR (breaths min−1). These four datasets are contin-
uously displayed on the mobile device for real-time user inspec-
tion and stored on the device’s local storage for future analysis. 
Finally, the data can be synced to a network accessible to the 
healthcare provider for real-time assessment of the patient 
and timely response for emergency events, such as a heart 
attack. A detail example of the graphical user interface of the 
Android application is shown in the Supporting Information 
(Figure S5). A human body has significant effects on the radia-
tion characteristics of the antenna due to the tissue’s scattering 
and absorption of the electromagnetic waves. Since the SHE is 
designed to integrate intimately with the human body, an effort 
was made to ensure the long-range connectivity of the BLE by 
incorporating a T-matching network with experimentally deter-
mined passive components to maximize the RF efficiency at 
2.45 GHz despite the extreme proximity to the skin (Figure S6, 
Supporting Information). As a result, the SHE maintained the 
wireless connectivity up to 15 m while operating on a user, con-
firming the tether-free characteristic of the device (real-time 
demonstration in Movie S1, Supporting Information).
2.2. Optimization of the Elastomeric Properties for Improved 
Signal Qualities
One of the key advantages of the SHE is that it obviates the 
need for application of conductive gels and adhesives. The 
extremely thin Au/PI electrodes (thickness: 1.2 µm) with 
the stretchable mesh layout can “hug” the complex skin surface 
structures while being able to freely deform with the dynamic 
movements of the tissue. While prior studies investigated the 
effects of reducing the membrane thickness with aims of pro-
viding conformal contact with the skin,[12,28,29] these results 
lacked the translation of the findings into practical applica-
tions—extremely thin membranes are not only fragile to 
retrieve from the skin but also are challenging to interface with 
rigid electronic packages. Here, we present a novel construc-
tion strategy for wearable electronics that preserves both the 
seamless electrode-to-skin contact and the means to intercon-
nect the thin-film electrodes with the on-board integrated cir-
cuit. A 500 µm thick elastomer was chosen to serve as the main 
substrate that helps maintain the electrodes’ integrity during 
the application and retrieval of the device (Figure 2A). While 
the increased substrate thickness ensures the electrode integ-
rity during device handling and retrieval, the added thickness 
could influence the level of conformal contact, which can have 
direct consequences in the qualities of ECG. Since conformal 
contact of the electrodes is dependent on design and material 
properties, an analytical model of the interfacial mechanics is 
applied to understand the criteria for conformal contact using 
the variables that represent skin’s roughness (λrough and hrough, 
Figure 2A inset) and layer information provided in Figure 2B. 
Conformal contact occurs when adhesion energy is greater than 
the sum of the skin’s elastic energy and electrode’s bending 
energy.[30] Adhesion energy is based on the elastomer’s work of 
adhesion (γelastomer) and exposed surface area. The elastic energy 
depends on the modulus of skin (Eskin) and λrough. Bending 
energy is determined by modeling the electrode as a composite 
material of Au, Cr, PI, and elastomer, contributing to an effec-
tive bending stiffness (EI). Here, we investigate the relationship 
between γelastomer and modulus (Eelastomer) necessary to achieve 
conformal contact of the electrode. We assume the on-board 
electronics are mechanically independent of the underlying 
electrodes and interconnects due to the thick, soft elastomer 
layer. Electrode design and layer thicknesses are held constant. 
For a given Eelastomer, there is a minimum γelastomer to provide 






















































 and α is the areal fraction of PI and Au.
The dotted boundary curve shown in Figure 2C represents 
the critical points and indicates the 500 µm thick elastomer 
properties required for conformal contact. Details of the anal-
ysis process leading up to expression (1) are described in the 
Supporting Information (Note S2). To examine the validity 
of the model, four different silicone elastomer products were 
used: 1) polydimethylsiloxane (PDMS, Dow Sylgard 184) with 
a base-to-cure ratio of 10:1, 2) Solaris (Smooth-On), 3) Ecoflex 
0030 (Smooth-On), and 4) Ecoflex GEL (Smooth-On). Since 
Ecoflex GEL’s extremely low modulus and tackiness prevented 
forming a usable layer, we modulated its properties by adding 
Ecoflex 0030 with two different weight ratios. First modifica-
tion was prepared by adding an equal part of Ecoflex GEL to 
Ecoflex 0030 (referred to as “Ecoflex1:1”) and the second mod-
ification was prepared by adding two parts of Ecoflex GEL to 
Ecoflex 0030 (referred to as “Ecoflex1:2”). This method allowed 
the formulation of five different candidate elastomer substrates 
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Figure 2. Mechanics and materials for enhanced physiological monitoring. A) Photo of the SHE lamination to the skin. The inset shows interfacial 
mechanics between skin and electrode during conformal contact. B) Illustration showing a nonconformal contact with the presence of gaps. The inset 
details the layer information. C) Determination of conformal contact: dotted curve represents the critical contact points of 500 µm thick elastomers. 
D) Skin-electrode contact impedance with five different elastomers. E) SNR of ECG collected with a subject during idle, walk, and run. F) Photo of 
showing the attribute of the oil-filled decoupling chamber with the bottom elastomer (red arrow) trailing the movement of the top circuit. G) Photo 
of capturing the effect of the decoupling chamber when a tweezer pushes the electrode layer. H) Computation of maximum principal strains induced 
on the Cu interconnects by linearly displacing a circular portion of electrode elastomer by 7 mm. Maximum strain in Cu is 250% and 0.25% for the 
absence and presence of the decoupling chamber, respectively. I) Comparison of ECG measured by two commercial devices (BioRadio and BioStamp) 
and SHE. SHE shows negligible motion artifacts.
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with varying degrees in the elastomer properties. Tensile stress 
tests using a digital force gauge (M5-5, Mark-10) fixed on a 
motorized test stand (ESM303, Mark-10) allowed us to measure 
the modulus of each material. The measured moduli for PDMS 
(1131.04 kPa), Solaris (251.53 kPa), and Ecoflex 0030 (32.23 kPa) 
were within the range of previously reported values with pos-
sible deviation arising from different mixing/curing conditions 
and the Poisson’s effect.[28,31,32] The moduli for Ecoflex1:1 and 
1:2 hybrids were measured to be 11.17 and 7.85 kPa, respec-
tively (Figure S7, Supporting Information). Experiments to 
obtain the work of adhesion for each sample were conducted by 
rolling metal cylinders down a track coated with each elastomer 
and observing the effective changes in the peel energy (∆γ) at 
various speeds.[33] We varied the rolling speeds by using five cyl-
inders with different dimensions and varying the track’s angles 
of incline (5°, 10°, 20°, and 30°). The set of data points for each 
elastomer allowed us to determine the work of adhesion by 
finding the y-intercept of the curve fit line. Details of the experi-
mental setup and results can be found in the Supporting Infor-
mation (Figures S8 and S9 and Table S2). Using the experimen-
tally obtained Eelastomer and γelastomer, the conformality criteria for 
each elastomer could be determined. As shown in Figure 2C, 
PDMS and Solaris were categorized as non-conformal, Ecoflex 
0030 as conformal with a small margin, and Ecoflex1:1 and 
1:2 as conformal with a large margin. Non-conformality of the 
elastomer and electrodes results in decreased effective elec-
trode area and is expected to reduce the amplitudes of the 
acquired ECG. Moreover, the gaps formed between the skin 
and metal film electrodes can deteriorate the signal qualities by 
introducing significant motion artifacts due to the movement-
induced changes in the resistance and capacitance properties 
of the interface. In order to confirm the influence of elastomer 
properties on electrode performances, we prepared five sets 
of electrodes with each integrated on a different elastomer 
and measured the electrode-to-skin contact impedance (Zc), 
a low quantity of which is desired in acquisition of low fre-
quency biopotentials, such as ECG. Minimizing Zc also helps 
maximize the differential amplifier’s ability to attenuate the 
common noise present to both the active and reference elec-
trodes, therefore increasing the signal-to-noise ratio (SNR).[34] 
Detail explanation for SNR can be found in the Experimental 
Section. The measurement was done by placing the electrodes 
over a forearm, which had been cleansed with Scotch tapes 
(three times) and an alcohol wipe and connecting the positive 
and negative electrodes to a test equipment (Checktrode Model 
1089 MK III, UFI). As Figure 2D reveals, contact impedance 
of the five sets of electrodes followed the same order found in 
Eelastomer and γelastomer, with Ecoflex 1:2 and PDMS exhibiting 
the lowest and highest impedances, respectively. To examine 
the consequences of measured contact impedance and its influ-
ence on the acquired ECGs, we collected ECGs using the five 
electrodes while the subject was stationary, walking, and run-
ning, and compared the SNR. As described in Figure 2E, the 
average trend in SNR measured by the five elastomer elec-
trodes followed the same order in Eelastomer, γelastomer, and Zc, 
with decreased SNR across all electrodes during walking and 
running. While electrodes on Ecoflex1:1 and 1:2 provided ECG 
with preserved features, all other electrodes suffered loss of fea-
tures and significant baseline drifts, especially when the user 
was moving. Details of the ECG data can be seen in the Sup-
porting Information (Figure S10).
While the conformal contact criteria for electrodes could be 
sufficiently achieved with Ecoflex1:2, portions of the SHE sol-
dered with the surface mount chips would disrupt the com-
pliant device mechanics, leading to poor device and electrode 
adhesion. In order to resolve this challenge, we designed a thin 
oil-filled decoupling chamber under the circuit’s footprint that 
separates the mechanics between the electrodes and electronics. 
The oil (Vegetable Glycerin, Essential Depot) was injected in the 
chamber using a micropipette and sealed with elastomer. 
The increase in the device adhesion could be observed when 
the device was peeled from a clean glass slide, with the elas-
tomer directly below the chamber trailing the movement of the 
electronic layer (Figure 2F). Visually, the oil chamber could be 
seen to allow the electrode layer to slide freely with respect to 
the electronic layer (Figure 2G). We developed an ABAQUS 
model representing the electronic section of the SHE to quan-
tify the effect of the decoupling chamber on the thin-film Cu 
interconnects, whose mechanical integrity is directly related to 
device operation. The model simulated an in-plane displace-
ment (7 mm) of a circular region (diameter = 3.5 mm) of the 
electrode layer for both “with” and “without” a decoupling 
chamber. While 7 mm was chosen arbitrarily and is beyond 
the range of expected displacements during a normal use of 
the device, the maximum strain observed in the Cu intercon-
nect for “with” scenario (ε = 0.00025%) was a thousandth of 
that of “without” scenario (ε = 0.25%), which approaches the 
yield strain of 0.5% for a 500 nm thick Cu film,[35] (Figure 2H). 
This result indicates that the decoupling chamber helps prevent 
damages to the electronics not only during the normal appli-
cation and removal of the device, but even from an accidental 
mishandling. The apparent increase in the adhesion of the 
device was further investigated by measuring the peel forces of 
the two “with” and “without” devices by peeling the devices off 
a forearm using a digital force gauge fixed on a motorized test 
stand. Integrating the “peel force versus displacement” curves 
of the two devices revealed that the total energy required to 
completely peel a device with a decoupling chamber (≈4.5 mJ) 
is more than twice the case without a decoupling chamber 
(≈2.1 mJ). Details of the experimental set up, description of the 
decoupling chamber, and the peel force plots can be found in 
the Supporting Information (Figure S11). Based on the results 
of the above analysis, we fabricated a complete SHE based on 
the Ecoflex1:2 elastomer and compared the ECG qualities to 
those acquired by commercially available devices, namely the 
BioRadio (Cleavmed Inc.) and BioStamp (MC10 Inc.). ECG 
was simultaneously recorded with SHE and BioRadio while the 
user performed a sequence of treadmill exercises with varying 
intensities. ECG with a BioStamp was recorded separately due 
to the overlap of the application site with the SHE. Photos of 
the device placement and orientation are show in the Sup-
porting Information (Figure S12). As shown in Figure 2I, all 
three ECGs exhibited the similar quality while the user was 
resting. The BioRadio’s data showed the most susceptibility to 
movement of any intensity, such as walking, and the artifacts 
buried the ECG, most likely due to the weights of the cables 
between the gel electrodes and the data acquisition unit. The 
BioStamp’s data showed improved signal qualities, however 
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still exhibited random spikes and baseline wandering likely due 
to the changes in the gel-mediated electrode contacts. The SHE 
did suffer mild baseline wander during high intensity exercise, 
but displayed ECG with preserved features that can be used for 
further analysis.
The long-term mechanical reliability of the SHE is tested 
by repeatedly exerting a metal cylinder (radius = 12.5 mm) 
against the circuit’s footprint using a uniaxial servohydraulic 
testing machine (MTS Systems, Inc). SHE’s continuous BLE 
connectivity to a nearby tablet was used as the indication for 
the electronics’ integrity since any damage to the BLE, ADC, 
or voltage regulator would result in a loss of signal in the tab-
let’s display. The SHE was displaced by the initial distance of 
5.08 mm for 1000 cycles. After every 1000 cycles, we incre-
mented the displacement by 2.54 mm, reaching the final dis-
placement of 15.24 mm and a total of 5000 cycles. Maintaining 
BLE connectivity throughout the experiment illustrates the 
SHE’s structural integrity as an electronic system despite the 
extreme case of repeated bending and stretching, whose criteria 
exceed the expected deformation during normal device applica-
tions. Details of the test setup and protocol are included in the 
Supporting Information (Figure S13 and Movie S2).
The long-term reliability of the stretchable connector was 
investigated by a set of cyclic bending and stretching up to 
1000 cycles, which is well beyond the expected strain range 
during the normal use of the SHE. The results in Figure S14 
(Supporting Information) indicate that the stretchable con-
nector maintained a stable resistance throughout 1000 cycles 
in both tests. The average variation in the resistance values 
were approximately 0.2% (0.5 Ω) and 0.4% (0.7 Ω) for cyclic 
stretching and bending, respectively. In addition, the long-term 
performance of the complete device was inspected via a cyclic 
stretching; ECG was recorded after cyclically stretching the SHE 
up to 30% for total of 400 cycles. The average SNRs obtained 
from 10 min long ECG recorded from each cycle indicate that 
the SHE maintained the functionality. Moreover, there was no 
indication that the repeated stretching negatively affected the 
functionality of the device, evidenced by the SNR values of 
greater than 20 dB throughout the test. At any step, all ECG fea-
tures, such as the P and T waves and the QRS complexes, could 
be sufficiently distinguished. Lastly, the maximum stretch-
ability of the SHE was inspected by stretching the device until 
ECG could not be recorded. However, the SHE maintained 
reliable functionality even up to 60%, which is far beyond the 
extent of stretching even in accidental scenarios, and the test 
was concluded (Figure S15, Supporting Information).
2.3. Development of the Classification Algorithms  
for Real-Time Monitoring of ECG, HR, RR, and Activity
Figure 3 describes the entire data analysis process and develop-
ment of CNN-based algorithm for ECG, HR, RR, and motion 
activity data recorded by the SHE. The raw ECG, accelera-
tion, and angular velocity data are simultaneously processed 
(Figure 3A) toward interpreting HR, RR, ECG annotation, and 
activity classification, where each process is represented as a sep-
arate column in Figure 3B. The corresponding outputs for each 
of the columns are shown in Figure 3C. Our ECG annotation 
model, named ECGSeq2Seq, uses a sequence-to-sequence 
annotation concept. The third column in Figure 3B shows a 
high-level representation of ECGSeq2Seq, broken down into 
blocks, with the black arrows representing residual connec-
tions (filter concatenation) between prior convolutional layers, 
and corresponding deconvolutional layers of similar size. The 
detailed description showing the processing steps involved 
with the four outputs is shown in the Supporting Informa-
tion (Figure S16). The ECG annotation model is detailed in 
Figure S17a (Supporting Information), along with the output 
dimensions from each layer. This is color coded to Figure S17b 
(Supporting Information), which details which individual layers 
belong under each block. The stem contains the initial steps 
performed by the model, involving dimensionality reductions 
through convolution operations and max pooling. Figure S17c 
(Supporting Information) shows the convolution parameters 
that are changed in the number of filters, filter size, and strides. 
It also shows the convolution layer is followed by a batch nor-
malization layer[36] and a linear activation. After the stem, we 
have four convolutional blocks, which are Inception-type blocks 
from Szegedy et al.’s work on image classification with deep 
convolutional networks.[21] The deconvolutional layers involve an 
up-sampling step along the sequence length, by a factor of two, 
along with a convolution layer. Several residual connections 
are made between the convolutional layers, and corresponding 
deconvolutional layers. Residual connections are necessary to 
combat the vanishing gradient problem, which causes very 
deep networks to saturate then degrade in accuracy during 
training.[37] The use of residual connections preserves gradient 
flow by bridging the gap between distant layers, improving 
training convergence and reducing overfitting.
This new ECGSeq2Seq network architecture uses an encoder-
decoder paradigm to perform semantic segmentation of ECG 
data, where each input data has corresponding output labels for 
each class. Long et al. used a similar method for pixel-to-pixel 
semantic segmentation of images.[22] Here, the deconvolutional 
layers seek to use the features extracted in the first half of the 
model and, when combined with an accurate beat-detection 
algorithm, is converted into a human-understandable ECG 
annotation. The PTB dataset, included data from 290 unique 
subjects along with diagnosis information, and included mul-
tiple 12-lead ECG recordings. The diagnosis information was 
used to label each of the datasets, separated into the following 
five categories (Figure 3C): 1) normal sinus rhythm (normal), 
2) myocardial infarction (MI), heart failure (HF), and miscel-
laneous arrhythmia (AR), 3) fusion beat (FB), 4) supraven-
tricular ectopic beats (SVEB), and 5) ventricular ectopic beats 
(VEB). This data set was combined with the INCART dataset, 
including 75 different recordings where each beat was individu-
ally labeled by a professional physician. This allows the model 
to be trained to recognize both ectopic beats as well as diag-
nose longer irregular rhythms. The PTB data were labeled after 
resampling from 1000 to 250 Hz and the INCART data were 
resampled from 257 to 250 Hz. As we intend to model anno-
tation as a sequence-to-sequence model, each input data point 
from the 8 s, 2000-point input was mapped to a 2000-point 
sequence of labels spanning the classes. Therefore, the input 
shape is (2000, 1), and the output shape is (2000, 9), where 
9 is the number of output classes. This differs from previous 
Adv. Sci. 2019, 6, 1900939
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CNN-based classification models in that it allows for precise 
beat labeling learned entirely from existing data. In order to 
train our ECGSeq2Seq annotation model, we calculate the loss 
as categorical cross-entropy and use the Adam optimizer[38] 
with a starting learning rate of 0.001. The data was separated 
into training and test sets using a 75–25% split, ensuring no 
overlap between the training and test set. This test was per-
formed four times, in a four-fold cross-validation. The training 
Adv. Sci. 2019, 6, 1900939
Figure 3. Development of CNN-based algorithms for real-time monitoring and classifications of four types of physiological signals. A) A set of ECG 
measured by an SHE (left) and motion activity, measured by change of acceleration (top-right) and orientation (bottom-right). B) Overview of data 
processing methods, separated into four columns: 1) HR estimation process, 2) RR estimation process, 3) ECG annotation via semantic segmentation 
network for detection of various types of cardiac disease (MI/HF/AR, FB, SVEB, and VEB), and 4) Classification network schema of motion activity 
data (idle, walk, stairs, run, and fall). C) Each column shows the respective outputs from the previous column in (B), in the order of HR, RR, ECG 
annotation, and motion activity class.
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set was further subdivided into the training and validation with 
an 80–20 split with no overlap. The total number of samples 
was 87 482 8 s windows at 250Hz. During the training process, 
the learning rate was reduced by a factor of 10 if there was no 
improvement to validation accuracy for consecutive epochs. 
The training and test accuracy appear in the Supporting Infor-
mation (Figure S17d). A similar model was used for classifica-
tion of activity from motion sensor data, as shown in the Sup-
porting Information (Figure S18a–c). This model was named 
as ActivityResNet, due to the use of residual connections. Data 
was collected from five subjects using continuous monitoring 
of motion activity with the SHE on the chest. Each subject per-
formed the following activities for 5 min each: idle sitting or 
standing, walking, walking upstairs, walking downstairs, and 
running.
Additionally, each subject was asked to fall five times while 
wearing the SHE for the fall detection portion of the training. 
The training process for this network was the same as the one 
for the ECGSeq2Seq model. The training and test accuracy are 
shown in Figure S18d (Supporting Information). The classifi-
cation results for each of these models are presented as con-
fusion matrices in Figure S19a,b (Supporting Information) for 
ECG and motion activity, respectively; the ECGSeq2Seq model 
achieved an average accuracy of 98.7 ± 1.4%, while the Activi-
tyResNet model achieved 98.9 ± 3.3% over fourfold cross valida-
tion. Samples from each of the abnormal ECG classes are sum-
marized in Figure S20 (Supporting Information).
2.4. In Vivo, Real-Time Validation of the Designed Algorithms 
with Human Subjects
Figure 4 demonstrates multiple scenarios along with in vivo, 
real-time analysis performed on a mobile device when using 
the SHE. This work validates the device performance on wire-
less, real-time detection of ECG abnormality and motion 
activity. Initially, ECG is recorded as a baseline from a normal 
healthy subject during idle activity. The same device on another 
subject successfully detects a symptom of VEB from occasional 
premature ventricular contractions in real-time (Figure 4A). 
Movie S3 (Supporting Information) shows real-time moni-
toring of HR, RR estimation and ECG annotation on a tablet 
device for a healthy subject with no anomalous or ectopic ECG 
activity. We also demonstrate the real-time detection and anno-
tation of ectopic beats from an unhealthy subject (Movie S4, 
Supporting Information). As shown in Figure 4B, the SHE 
offers a wireless, portable, real-time monitoring of ECG, HR, 
and RR during various activities, including walking, running, 
and walking upstairs. Any smartphone or tablet via Bluetooth 
connection can monitor the physiological signals in real time, 
while alerting any abnormality of ECG and emergency of 
falling (details appear in Movie S5, Supporting Information). 
To validate the device performance, we compare the SHE with 
a commercial system (BioRadio) in monitoring of ECG and 
respiratory inductance plethysmography (RIP). Both devices 
recorded signals simultaneously on a subject performing 
various activities (walking, running, and idle; Figure S19, 
Supporting Information). The corresponding set of ECG, 
derived HR, and RR for both devices is shown in Figure S21a–c 
(Supporting Information), respectively. The SHE-derived HR is 
compared with the BioRadio data using a regression plot in the 
Supporting Information (Figure S18d) showing a high coher-
ence with a slope of 0.9760, and a coefficient of determination 
of R2 = 0.9844. Comparison of RR data (Figure S21e, Sup-
porting Information) also shows a good agreement with a slope 
of 1.0545, and a coefficient of determination of R2 = 0.9504. 
This result is quite significant considering the difficulty of 
deriving respiratory rate from a single ECG lead. Further tests 
were conducted to validate the SHE’s accuracy in detecting RR. 
In this simulated scenario, both the SHE and BioRadio RIP 
simultaneously recorded an idle subject who increased the RR 
over time. The result shows that the SHE-derived respiration 
curves closely represent that of the commercially available RIP 
device’s respiration curves (Figure S22a,b, Supporting Infor-
mation). Figure S22c (Supporting Information) shows the 
extended RR recording over time for 5 min with a high cor-
respondence between the SHE and BioRadio. A regression plot 
comparing the two RR data (Figure S22d, Supporting Infor-
mation) shows a coefficient of determination of R2 = 0.9776. 
Overall, the SHE shows excellent performance when compared 
with the commercial hardware for monitoring representative 
physiological signals.
2.5. Demonstration of the SHE as a Versatile Clinical  
and Research Tool
As described in Figure 2, the SHE can be distinguished for its 
low-profile integration with the skin without disrupting the 
wearer’s behavior while preserving the quality of physiolog-
ical signals despite movements of varying intensities. To fully 
depict its utility as a viable, versatile clinical and research tool, 
we employed a set of in vivo studies involving both humans 
and animals in varying contexts. First, we demonstrated the use 
of the SHE for real-time monitoring of ECG and BPM during 
a treadmill test (Figure 5A), which is known for its diagnostic 
and prognostic values in the subject’s cardiac function. For this 
demonstration, we employed a modified Bruce protocol, which 
is consisted with five 3 min stages with progressively increasing 
workloads (determined by speed and incline) followed by 
10 min of rest. Figure 5B captures the data recorded by the 
SHE throughout the 24 min protocol with top plot labels indi-
cating the speed and inclination of each 3 min stage. The BPM 
data successfully describes the workload-dependent changes 
in the heart rate with the peak effort recorded (BPM = 176) at 
the end of stage 5. While not directly part of a standard Bruce 
protocol, motion data could be successfully classified according 
to the subject’s activities on a treadmill for “Idle,” “Walking,” 
and “Running” (details of the treadmill exercise appear in 
the Supporting Information, Figure S23 and Movie S6). The 
modular nature of the SHE allows the integration of alterna-
tive substrates other than elastomers depending on the applica-
tion. Specifically, the utilization of a breathable medical tape, 
such as Tegaderm (3M), offers specific advantages of improved 
breathability and increased adhesion. Detail performance of 
the Tegaderm-integrated device is shown in Figure S24 (Sup-
porting Information). To demonstrate the advantages of the 
Tegaderm-integrated SHE, we conducted a study verifying the 
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Figure 4. In vivo, real-time validation of the designed algorithms with human subjects. A,B) A real-time, ambulatory monitoring of ECG and motion 
activity with a SHE on a human subject. At both A) idle and B) active movements of a subject, the device clearly detects VEB in the annotation model. 
A variety of activities includes walking, climbing stairs, and running (B). The four zoom-in plots in (B) show detail 2 s window of ECG waveforms from 
corresponding activity.
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feasibility of wearing the device for prolonged wear time up to 
1 week (Figure S25), which is the suggested period for increasing 
the detection rates for subclinical arrhythmias and atrial fibril-
lation.[39,40] As shown in Figure 5C, the Tegaderm-integrated 
SHE was applied to the chest of a subject, who was instructed 
to carry out daily tasks, such as walking, driving, showering, 
and sleeping until the noticeable degradation in the signals 
were observed. As shown in Figure 5D, the ECG waveforms 
between Day 1 and Day 7 showed no significant changes with a 
slight decrease in SNR by 3.3 dB due to the accumulated dead 
cells on epidermis.[28] However, an abrupt decrease in SNR 
was observed in the 8th day, where significant noise was visible 
in the waveform. This is likely due to eventual separation of 
the adhesive and electrodes from the skin. Photos describing 
the daily progression of the device’s visual appearance and the 
waveforms describing the sudden changes in ECG quality 
Adv. Sci. 2019, 6, 1900939
Figure 5. Demonstration of the SHE as a versatile clinical and research tool. A) Demonstration of the SHE application as ECG and HR monitor for 
a treadmill exercise including walking and running (Movie S6, Supporting Information). B) Implementation of a modified Bruce protocol (cardiac 
diagnostic test) and overlay of SHE’s BPM data on plot areas whose color gradients represent the level of exercise intensity (top labels indicate speed 
and angle of inclination). C) Photos of a Tegaderm-integrated SHE where the elastomer substrate has been substituted with a medical film (left), 
whose waterproof capability (right) enables a prolonged application exceeding 7 d with daily activities. D) Comparison of ECG collected at the begin-
ning and end of the 7 d application of the device on the chest. No significant degradation in the signal qualities is observed with a decrease in SNR 
of only 3.3 dB. E) Demonstration of the SHE’s utility in an in vivo animal study, involving ambulatory ECG monitoring of a rat model (left; device 
on the shaved back). With the ultrathin SHE on the back, this rat shows no change in activation patterns (right; after awakening from anesthesia; 
Movie S7, Supporting Information). A Tegaderm-integrated SHE is applied for simultaneous recording of ECG with an implanted electronic system 
(TR50BB) of a rat with a high degree atrioventricular block. F) The ECG waveform and BPM data, generated by two devices, show nearly identical trends 
(Movie S8, Supporting Information).
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are included in Figure S25 (Supporting Information). Ultimately, 
the Tegaderm-integrated SHE presented the feasibility of 
continuous and prolonged ECG monitoring for 7 d with the 
advantages of the real-time monitoring functionalities. Con-
tinuous cardiac monitoring of live animals is essential part in 
in vivo investigations involving various cardiac disease models. 
In such cases, the standard protocol is to surgically implant a 
biopotential telemeter in the animal along with lead wires for 
necessary ECG vectors. However, the invasive route is disad-
vantageous since the surgical procedure bears risks of the ani-
mal’s health and life. Moreover, it requires a trained personnel 
and equipment necessary to perform the surgical procedure. 
Lastly, currently available invasive monitoring solutions are 
costly with telemeter units ranging ≈$3000 and require propri-
etary hardware for data acquisition, making the whole system 
cost of ≈$10 000. In this sense, the SHE-based monitoring 
could contribute to studies involving live animals since it is 
non-invasive, low-cost, and does not obstruct the activity of the 
animals. However, the structure of an animal’s skin is wildly 
different from the human’s, which does not warrant the same 
conformal contact. Thus, the integration of the medical film, 
Tegaderm, is an attractive option since the adhesive can help 
secure the device regardless of the animal’s skin conditions and 
the level of activities. To verify the feasibility of the SHE-based 
in vivo cardiac monitoring, we applied the device over a shaved 
back of a high degree atrioventricular block model. Prior to 
the SHE application, a commercial, implantable telemeter 
unit (TR50BB, KAHA Sciences) was inserted in the abdominal 
cavity of the rat and sensing wire electrodes were sutured to the 
pectoral muscles (Figure 5E). As shown in Figure 5F, the two 
simultaneously recorded ECG data exhibited comparable per-
formances. Similarly, the two BPM data, derived from the two 
devices, precisely overlapped one another, indicating the SHE’s 
capability for advanced analysis involved with heart rhythms. 
Details of the experiment set up and data comparison between 
TR50BB and SHE are included in the Supporting Information 
(Figure S26 and Movies S7 and S8).
3. Discussion
For over a decade, the direct integration of electronics with soft 
biological tissues, such as human skin, with aims for persis-
tent health monitoring has been a research topic for many. The 
most notable breakthrough was perhaps showcased by Kim 
et al. in 2011,[12] in which the authors employed thin-film pro-
cessing techniques and stretchable interconnect schemes to 
match the mechanical properties of human skin and to serve 
as multifunctional healthcare platform. However, fundamental 
physics, data transmission, and reliability issues limit the for-
mation of completely thin membrane electronics with perfor-
mances that match commercially available rigid chip packages 
with active wireless telemetry. The hybrid electronic platform 
demonstrated by the SHE is an engineering solution to the 
technological gap that lies between “skin-like properties” and 
“functionality.” The 500 µm thick, low modulus elastomer layer 
preserves the thin-film properties of the nanomembrane Au 
electrodes and allows the stable monitoring of ECG without the 
use of a conductive gel. The mechanical decoupling chamber 
below the circuit’s footprint helps separate the influence of the 
chip components on the electrodes and improves the overall 
adhesion of the SHE to skin. The decoupled structure therefore 
allowed us to inherit the merits of both thin, skin-conforming 
electrodes and advanced circuit solutions, such as BLE, front-
end amplifier, and motion sensing. As shown throughout the 
manuscript, the thin and compact electronic component of SHE 
allowed us to design and optimize the adhesive property of the 
completed device according to each study. The extremely low 
modulus elastomer, such as Ecoflex1:2, is particularly attractive 
for its gentle adhesion and minimum impact on the skin. Con-
sequently, we believe that the SHE will find its most utility in 
pediatric patients with congenital heart diseases, whose skin is 
too fragile and sensitive for repeated application and removal 
of adhesives and gels. Moreover, incorporation of a commercial 
medical adhesive as the substrate material highlighted the 
SHE’s versatility in more demanding scenarios described in 
Figure 5, where the feasibility for wireless, prolonged, real-time 
monitoring of cardiac abnormalities with aims for increased 
detection rates for early-stage cardiac conditions is assessed. 
As a follow-up validation study, the SHE’s diagnostic efficiency 
should be assessed by comparing the detection rates with com-
mercial devices in a clinical setting. The success of the com-
parison study will help both the patients and clinicians obtain 
the correct cardiac conditions and rule out false negatives and 
positives in outpatient settings. As described in Figure 5E,F, 
the successful monitoring of the rat model’s cardiac activity 
points to future studies where the compact and low-profile SHE 
enables a low-cost, non-invasive, and continuous monitoring 
of animal models. The real-time ECG classification algorithm 
could be designed to detect not only the abnormalities, but 
also the onset of action for the administered drugs. Such smart 
functionality could provide the researchers an objective tool 
and the better control over animal experiments. In this paper, 
MLV2 was used as an analog to precordial lead V2 using two 
bipolar surface electrodes. In order to demonstrate the preci-
sion of real-time annotation, we demonstrated the use of con-
volutional neural networks trained on two publicly available 
12-lead ECG datasets, using only the V2 lead. We trained a sep-
arate model recording ECG using MLV2 demonstrating similar 
ability to detect arrhythmia and annotate ectopic beats in real-
time. We demonstrated this capability with a subject exhibiting 
a symptom of VEB (specifically, a premature ventricular con-
traction). However, there is not enough data recorded with our 
MLV2 lead to create a fully fledged annotation model, as the 
one used for the V2 leads from the PTB and INCART datasets, 
covering nine classes. In future studies, we aim to acquire ECG 
data from nine or more classes using MLV2 with the SHE to 
ensure high-quality recordings in at-home idle and ambulatory 
settings. This will allow for a more robust annotation and clas-
sification scheme that can be used in any at-home setting with 
reliable detection and accuracy.
4. Conclusion
The collection of materials presented here indicates that the 
wireless SHE offers real-time, smart, and ambulatory moni-
toring of human health. This work includes a comprehensive 
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study that lays the technological basis for settings where per-
sistent and multifunctional health monitoring is desirable with 
minimal impact on the patient’s condition and lifestyle. The 
persistent, yet comfortable, integration of SHE-type monitors, 
along with the continuous and wireless acquisition of multiple 
health conditions, will serve as a powerful assistance to the 
practice of medicine.
5. Experimental Section
Elastomer Substrate Preparation: Polystyrene dishes (FB0875714, 
Fisher Scientific) were used as cast molds for elastomer preparation. 
A freshly mixed elastomer (9.8 g) was poured onto the dish to achieve 
the 500 µm thickness. For elastomers with short pot life, such as 
Ecoflex1:1 and 1:2, a spin coater was used to help distribute the material 
evenly across the dish. Cured elastomers were cut and removed from 
the dish for thin-film integration.
Microfabrication of Thin-Film Structures and Transfer onto Elastomer: 
Standard microfabrication processes, such as photolithography, wet/
dry etching, physical vapor deposition, spin coating, and vacuum oven 
curing, were used to construct the thin-film metal/polymer composite 
layers (electrodes, interconnection, and connector). Details of the 
fabrication steps appear in Supporting Information Note 1. Completed 
thin films were peeled from the donor substrates (PDMS-coated silicon 
wafers) using a water-soluble tape (ASWT-2, Aquasol). The backsides of 
the thin films were deposited with layers of Ti (5 nm) and SiO2 (20 nm) 
using an electron beam deposition tool. Elastomer substrates were 
treated with a UV-ozone dry stripper (UV-1, Samco) for 5 s for surface 
activation. The thin films were then laminated to the activated elastomer 
and gently pressed to form the OSiO covalent bonds. Water 
soluble tape was removed by rinsing with water and foam tip swabs, 
leaving behind the bonded thin-film structure on the elastomer.
SNR Calculation for ECG: SNR measurements were made by splitting 
an ECG recording into windows of 8 s in length, where the peaks were 
isolated using a variation on the Pan-Tompkins algorithm for detecting 
the QRS complex.[41] After the convolutional step (which can be seen 
in Figure 3B, first column), where the relative amplitude of the signal 
peaks is found, the peaks were removed using a high-order median filter 
(order = 99), leaving only the relevant noise. The signal-to-noise ratio 
was then calculated using the average amplitude of each QRS complex 
versus the average noise amplitude. The SNR of a single window was 
calculated as follows 
A
A
















, and was averaged over 
the number of windows in the recording.
In Vivo Experiment with Human Subjects: The study involved eight 
volunteers ages 18–40 and the study was conducted by following the 
approved IRB protocol (# H17212) at Georgia Institute of Technology. 
Prior to the in vivo study, all subjects agreed with the study procedures 
and provided signed consent forms.
In Vivo Experiment with Animals: The study involved two rats and 
the study was conducted by following the approved IACUC protocol 
#2003043 “Cardiac rhythm restoration in a small animal model of heart 
disease” at Emory University.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
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